| Trial ID: | L2253 |
| Source ID: | NCT00501930
|
| Associated Drug: |
Gsk189075
|
| Title: |
A Study to Evaluate and Study Drug Levels in Blood Plasma When Giving High Doses of GSK189075 to Healthy Volunteers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: GSK189075
|
| Outcome Measures: |
Primary: Clinical laboratory tests, ECGs, adverse events, screening, Day -1 - 3 all periods, follow up | Secondary: blood plasma levels of GSK189075, Day 3|clinical lab tests, each day
|
| Sponsor/Collaborators: |
Sponsor: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-04
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2012-06-04
|
| Locations: |
GSK Investigational Site, Madison, Wisconsin, 53704, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00501930
|
